Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$107.59B
Total volume
BTC 49.61%     ETH 15.34%
Dominance

Astria Therapeutics ATXS Stock

14.08 USD {{ price }} 3.492643% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
772.76M USD
LOW - HIGH [24H]
13.38 - 14.79 USD
VOLUME [24H]
1.33M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.42 USD

Astria Therapeutics Price Chart

Astria Therapeutics ATXS Financial and Trading Overview

Astria Therapeutics stock price 14.08 USD
Previous Close 10.66 USD
Open 10.72 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 9.75 - 10.91 USD
52 Week Range 2.56 - 16.28 USD
Volume 408.22K USD
Avg. Volume 191.2K USD
Market Cap 285.3M USD
Beta (5Y Monthly) 0.916197
PE Ratio (TTM) N/A
EPS (TTM) -2.42 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 24.43 USD

ATXS Valuation Measures

Enterprise Value 168.09M USD
Trailing P/E N/A
Forward P/E -4.544643
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 2.4553788
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Astria Therapeutics Stock Price History

Beta (5Y Monthly) 0.916197
52-Week Change 266.18%
S&P500 52-Week Change 20.43%
52 Week High 16.28 USD
52 Week Low 2.56 USD
50-Day Moving Average 11.92 USD
200-Day Moving Average 11.62 USD

ATXS Share Statistics

Avg. Volume (3 month) 191.2K USD
Avg. Daily Volume (10-Days) 291.12K USD
Shares Outstanding 28.03M
Float 20.17M
Short Ratio 4.29
% Held by Insiders 0.95%
% Held by Institutions 81.71%
Shares Short 536.69K
Short % of Float 2.19%
Short % of Shares Outstanding 1.91%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -19.38%
Return on Equity (ttm) -29.71%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -47699000 USD
Diluted EPS (ttm) -2.51
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 213.33M USD
Total Cash Per Share (mrq) 7.61 USD
Total Debt (mrq) 794K USD
Total Debt/Equity (mrq) 0.38 USD
Current Ratio (mrq) 32.286
Book Value Per Share (mrq) 4.146

Cash Flow Statement

Operating Cash Flow (ttm) -44227000 USD
Levered Free Cash Flow (ttm) -27201250 USD

Profile of Astria Therapeutics

Country United States
State MA
City Boston
Address 75 State Street
ZIP 02109
Phone 617 349 1971
Website https://www.astriatx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 45

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

Q&A For Astria Therapeutics Stock

What is a current ATXS stock price?

Astria Therapeutics ATXS stock price today per share is 14.08 USD.

How to purchase Astria Therapeutics stock?

You can buy ATXS shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Astria Therapeutics?

The stock symbol or ticker of Astria Therapeutics is ATXS.

Which industry does the Astria Therapeutics company belong to?

The Astria Therapeutics industry is Biotechnology.

How many shares does Astria Therapeutics have in circulation?

The max supply of Astria Therapeutics shares is 54.9M.

What is Astria Therapeutics Price to Earnings Ratio (PE Ratio)?

Astria Therapeutics PE Ratio is now.

What was Astria Therapeutics earnings per share over the trailing 12 months (TTM)?

Astria Therapeutics EPS is -2.42 USD over the trailing 12 months.

Which sector does the Astria Therapeutics company belong to?

The Astria Therapeutics sector is Healthcare.

Astria Therapeutics ATXS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16379.46 USD
-0.12
4.79B USD 16347.38 USD 16420.92 USD 4.79B USD
NASDAQ Global Market Composite NQGM 2283.98 USD
+0.52
2277.12 USD 2296.84 USD
NASDAQ HealthCare IXHC 1011.84 USD
-0.04
1011.35 USD 1017.55 USD